 NEW YORK, Feb. 23, 2021 PRNewswire -- Hoth Therapeutics, Inc. NASDAQ: HOTH, a biopharmaceutical company, today announced today the successful completion of a pre-IND meeting with the U.S. Food and Drug Administration FDA regarding the Companys development plan for their HT-001... 